FibroBiologics, Inc. — SEC Form D Filing
FibroBiologics, Inc. filed an SEC Form D on December 16, 2025, reporting $1.73M raised in Pharmaceuticals.
Form D filing details
- Filing
- SEC Form D
- Filing date
- December 16, 2025
- Amount reported
- $1.73M
- Round stage
- Seed
- Industry
- Pharmaceuticals
- Website
- https://fibrobiologics.com
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
The provided website content is exclusively a cookie consent banner and does not contain information about FibroBiologics, Inc.'s actual business, products, or services.
Solution
Based solely on the provided content, it is impossible to determine the specific product or service FibroBiologics, Inc. offers to address any particular problem, as the content only details cookie usage.
Why now
The specific timing catalyst is unclear from available information.
Source: SEC EDGAR Form D filing